<DOC>
	<DOCNO>NCT01033604</DOCNO>
	<brief_summary>The application Glyaderm skin restoration intend provide stable wound closure enhance pliability function skin favourable scar . The dermal substitute would affordable widespread application full thickness skin defect burn . Patients burn wound large full thickness wound evaluate enrollment . All burn wound clearly full thickness clinical assessment treat first 48 hour hydrocolloid paste cover paraffin gauze dress . This hydrocolloid paste combine paraffin gauze ensure maintenance moist wound environment first 48 hour prior assessment LDI randomization . This standard treatment burn admit Ghent Burn Centre . Wounds photograph daily basis . In order obtain optimal preparation LDI , burn wound meticulously debrided dressing change . LDI reliable 48-72 hour . Patients whose burn wound meet inclusion criterion , i.e . full thickness burn LDI value &lt; 200 randomized receive either GLYADERM split skin graft versus split skin graft alone .</brief_summary>
	<brief_title>Glyaderm + Split Thickness Skin Graft Versus Split Thickness Skin Graft Alone Full Thickness Skin Defects</brief_title>
	<detailed_description />
	<criteria>All burn wound flux value measure Laser Doppler Imaging , correspond expect healing time longer 28 day . Dark blue color palette LDI software flux value 200 All clearly full thickness burn clinical assessment do two plastic surgeon thereafter treat FlammaceriumÂ® . Wounds treat hydrocolloid paste prior LDI low flux value &lt; 200 All assessment do first day final decision day three Possibility follow complete treatment schedule final graft take subsequently wound heal finally participation complete followup schedule Informed consent obtain TBSA Full Thickness Burn &lt; 40 % All burn wound flux value measure Laser Doppler Imaging , correspond faster heal time ( flux value &gt; 200 ) TBSA &gt; 40 % Not follow complete treatment schedule miss evaluation followup period Patient condition ( ) seriously compromise patient 's ability complete study . Patient participate another study utilize investigational drug within previous 30 day Patient one medical condition ( ) , diabetes , include renal , hepatic , hematologic , neurologic , immune disease opinion investigator would make patient inappropriate candidate study Patients wish decline study No inform consent start trial</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>